Stage 3 Ovarian Cancer Treatment in Ahmedabad — Dr. Nishtha Tripathi Patel is an ESGO-certified gynaecological oncosurgeon offering specialist treatment for stage 3 ovarian cancer treatment at Sterling Hospitals, KD Hospital and Welcare Speciality Hospital in Ahmedabad.
On this page
- What this stage means
- Recommended treatment pathway
- Adjuvant therapy
- Outlook and survival data
- Booking
- FAQs
What does this stage mean?
Stage 3 ovarian cancer has spread beyond the pelvis to the peritoneum and/or retroperitoneal lymph nodes. The standard approach is either upfront cytoreductive surgery (often with HIPEC) followed by chemotherapy, OR neoadjuvant chemotherapy (3 cycles) followed by interval cytoreductive surgery + HIPEC, then completion chemotherapy.
For broader information see our cancer overview and treatment page.
Recommended treatment pathway
Stage 3 ovarian cancer has spread beyond the pelvis to the peritoneum and/or retroperitoneal lymph nodes. The standard approach is either upfront cytoreductive surgery (often with HIPEC) followed by chemotherapy, OR neoadjuvant chemotherapy (3 cycles) followed by interval cytoreductive surgery + HIPEC, then completion chemotherapy.
Adjuvant therapy
Carboplatin-paclitaxel 6 cycles total. HIPEC added at interval surgery has demonstrated survival benefit in Van Driel NEJM 2018. Bevacizumab and PARP inhibitor maintenance based on genetic profile.
Outlook
Median overall survival 4-5 years with optimal cytoreduction + HIPEC; significantly lower with suboptimal surgery.
External authoritative reference: NCCN Guidelines and ESGO Recommendations.
Booking
For an individualised treatment plan, share your reports on WhatsApp (+91 76988 00333) or book an appointment. Second opinions are available for patients already under care elsewhere.
FAQs
Where is stage 3 ovarian cancer treatment performed in Ahmedabad?
Dr. Nishtha Tripathi Patel treats this disease stage at Sterling Hospitals (Sindhubhavan), KD Hospital, and Welcare Speciality Hospital in Ahmedabad. The hospital is chosen based on the specific procedure needed and patient preference.
What is the typical hospital stay?
For minimally invasive surgery (robotic or laparoscopic), hospital stay is typically 3-4 days. For cytoreductive surgery or HIPEC, stay extends to 7-10 days. Chemoradiation is outpatient over 5-7 weeks.
What is the likely outcome?
Median overall survival 4-5 years with optimal cytoreduction + HIPEC; significantly lower with suboptimal surgery. Outcomes are stage-dependent and individual; the figures above are averages from published series.
Is fertility preservation possible?
Fertility preservation is not standard for this stage. Egg or embryo cryopreservation may be considered before chemotherapy if applicable.
Can I get a second opinion before deciding?
Yes. Share your reports on WhatsApp (+91 76988 00333). Dr. Nishtha provides independent review of stage, pathology, imaging and proposed treatment within 24-48 hours.
Reviewed by Dr. Nishtha Tripathi Patel, MBBS, DGO, DNB, Fellowship Gynaecological Oncology, ESGO-certified.